US Stock MarketDetailed Quotes

LBPH Longboard Pharmaceuticals

Watchlist
  • 59.780
  • +0.050+0.08%
Close Nov 13 16:00 ET
  • 59.780
  • 0.0000.00%
Post 16:36 ET
2.33BMarket Cap-26568P/E (TTM)

Longboard Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-54.98%-20.6M
-42.20%-19.13M
-15.88%-15.18M
-33.64%-50.87M
-14.03%-11.03M
-34.87%-13.29M
-58.02%-13.45M
-30.64%-13.1M
-54.07%-38.06M
-70.41%-9.67M
Net income from continuing operations
-89.73%-24.54M
-45.24%-21.79M
-30.81%-14.99M
-23.84%-54.42M
-32.51%-15.03M
-11.54%-12.93M
-31.49%-15M
-19.37%-11.46M
-58.09%-43.95M
-29.32%-11.35M
Depreciation and amortization
0.00%1K
0.00%2K
0.00%1K
0.00%5K
0.00%1K
0.00%1K
0.00%2K
0.00%1K
400.00%5K
0.00%1K
Change In working capital
397.52%3M
169.52%2.89M
96.07%-92K
-59.38%1.27M
184.88%3.54M
-221.13%-1.01M
-50.96%1.07M
-104.19%-2.34M
222.54%3.12M
-50.24%1.24M
-Change in prepaid assets
-423.35%-637K
-479.33%-1.58M
3.51%-770K
304.37%374K
-11.55%559K
-11.26%197K
-68.96%416K
66.43%-798K
88.88%-183K
-41.59%632K
-Change in payables and accrued expense
186.64%1.55M
2,639.68%3.45M
1,428.57%3M
-101.79%-42K
701.27%1.43M
-4,260.47%-1.79M
-53.51%126K
-91.35%196K
81.63%2.34M
-127.82%-237K
-Change in other working capital
258.32%2.09M
91.71%1.02M
-33.53%-2.32M
-2.50%935K
83.61%1.56M
2.64%583K
-7.97%531K
-67.89%-1.74M
-27.46%959K
50.35%848K
Cash from discontinued investing activities
Operating cash flow
-54.98%-20.6M
-42.20%-19.13M
-15.88%-15.18M
-33.64%-50.87M
-14.03%-11.03M
-34.87%-13.29M
-58.02%-13.45M
-30.64%-13.1M
-54.07%-38.06M
-70.41%-9.67M
Investing cash flow
Cash flow from continuing investing activities
181.27%33.05M
-359.81%-20.69M
-3,896.14%-230.92M
242.01%24.23M
-172.77%-1.56M
1,232.09%11.75M
567.39%7.96M
128.58%6.08M
58.09%-17.06M
162.35%2.15M
Net investment purchase and sale
181.27%33.05M
-359.81%-20.69M
-3,896.14%-230.92M
242.01%24.23M
-172.77%-1.56M
1,232.09%11.75M
567.39%7.96M
128.58%6.08M
58.07%-17.06M
162.41%2.15M
Cash from discontinued investing activities
Investing cash flow
181.27%33.05M
-359.81%-20.69M
-3,896.14%-230.92M
242.01%24.23M
-172.77%-1.56M
1,232.09%11.75M
567.39%7.96M
128.58%6.08M
58.09%-17.06M
162.35%2.15M
Financing cash flow
Cash flow from continuing financing activities
-90.58%560K
116.80%21K
1,240.84%286.4M
6,899.77%30.19M
777.93%3.01M
5.95M
-125K
21.36M
-100.58%-444K
-444K
Net common stock issuance
--0
--0
1,210.22%301.35M
--31.79M
--2.83M
--5.96M
--0
--23M
--0
--0
Proceeds from stock option exercised by employees
239.66%591K
-47.92%25K
--48K
--490K
--268K
--174K
--48K
--0
--0
--0
Net other financing activities
83.51%-31K
97.69%-4K
-814.27%-14.99M
-369.82%-2.09M
---85K
---188K
---173K
---1.64M
94.66%-444K
----
Cash from discontinued financing activities
Financing cash flow
-90.58%560K
116.80%21K
1,240.84%286.4M
6,899.77%30.19M
777.93%3.01M
--5.95M
---125K
--21.36M
-100.58%-444K
---444K
Net cash flow
Beginning cash position
-23.90%14.84M
117.50%54.64M
33.00%14.33M
-83.76%10.78M
27.55%23.91M
-29.63%19.5M
-28.30%25.12M
-83.76%10.78M
19.94%66.35M
-75.16%18.75M
Current changes in cash
195.30%13.01M
-608.49%-39.8M
180.97%40.31M
106.40%3.56M
-20.19%-9.58M
149.11%4.41M
23.28%-5.62M
145.82%14.35M
-603.82%-55.57M
12.56%-7.97M
End cash Position
16.50%27.85M
-23.90%14.84M
117.50%54.64M
33.00%14.33M
33.00%14.33M
27.55%23.91M
-29.63%19.5M
-28.30%25.12M
-83.76%10.78M
-83.76%10.78M
Free cash flow
-54.98%-20.6M
-42.20%-19.13M
-15.88%-15.18M
-33.64%-50.87M
-14.03%-11.03M
-34.87%-13.29M
-58.02%-13.45M
-30.64%-13.1M
-53.97%-38.06M
-70.32%-9.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -54.98%-20.6M-42.20%-19.13M-15.88%-15.18M-33.64%-50.87M-14.03%-11.03M-34.87%-13.29M-58.02%-13.45M-30.64%-13.1M-54.07%-38.06M-70.41%-9.67M
Net income from continuing operations -89.73%-24.54M-45.24%-21.79M-30.81%-14.99M-23.84%-54.42M-32.51%-15.03M-11.54%-12.93M-31.49%-15M-19.37%-11.46M-58.09%-43.95M-29.32%-11.35M
Depreciation and amortization 0.00%1K0.00%2K0.00%1K0.00%5K0.00%1K0.00%1K0.00%2K0.00%1K400.00%5K0.00%1K
Change In working capital 397.52%3M169.52%2.89M96.07%-92K-59.38%1.27M184.88%3.54M-221.13%-1.01M-50.96%1.07M-104.19%-2.34M222.54%3.12M-50.24%1.24M
-Change in prepaid assets -423.35%-637K-479.33%-1.58M3.51%-770K304.37%374K-11.55%559K-11.26%197K-68.96%416K66.43%-798K88.88%-183K-41.59%632K
-Change in payables and accrued expense 186.64%1.55M2,639.68%3.45M1,428.57%3M-101.79%-42K701.27%1.43M-4,260.47%-1.79M-53.51%126K-91.35%196K81.63%2.34M-127.82%-237K
-Change in other working capital 258.32%2.09M91.71%1.02M-33.53%-2.32M-2.50%935K83.61%1.56M2.64%583K-7.97%531K-67.89%-1.74M-27.46%959K50.35%848K
Cash from discontinued investing activities
Operating cash flow -54.98%-20.6M-42.20%-19.13M-15.88%-15.18M-33.64%-50.87M-14.03%-11.03M-34.87%-13.29M-58.02%-13.45M-30.64%-13.1M-54.07%-38.06M-70.41%-9.67M
Investing cash flow
Cash flow from continuing investing activities 181.27%33.05M-359.81%-20.69M-3,896.14%-230.92M242.01%24.23M-172.77%-1.56M1,232.09%11.75M567.39%7.96M128.58%6.08M58.09%-17.06M162.35%2.15M
Net investment purchase and sale 181.27%33.05M-359.81%-20.69M-3,896.14%-230.92M242.01%24.23M-172.77%-1.56M1,232.09%11.75M567.39%7.96M128.58%6.08M58.07%-17.06M162.41%2.15M
Cash from discontinued investing activities
Investing cash flow 181.27%33.05M-359.81%-20.69M-3,896.14%-230.92M242.01%24.23M-172.77%-1.56M1,232.09%11.75M567.39%7.96M128.58%6.08M58.09%-17.06M162.35%2.15M
Financing cash flow
Cash flow from continuing financing activities -90.58%560K116.80%21K1,240.84%286.4M6,899.77%30.19M777.93%3.01M5.95M-125K21.36M-100.58%-444K-444K
Net common stock issuance --0--01,210.22%301.35M--31.79M--2.83M--5.96M--0--23M--0--0
Proceeds from stock option exercised by employees 239.66%591K-47.92%25K--48K--490K--268K--174K--48K--0--0--0
Net other financing activities 83.51%-31K97.69%-4K-814.27%-14.99M-369.82%-2.09M---85K---188K---173K---1.64M94.66%-444K----
Cash from discontinued financing activities
Financing cash flow -90.58%560K116.80%21K1,240.84%286.4M6,899.77%30.19M777.93%3.01M--5.95M---125K--21.36M-100.58%-444K---444K
Net cash flow
Beginning cash position -23.90%14.84M117.50%54.64M33.00%14.33M-83.76%10.78M27.55%23.91M-29.63%19.5M-28.30%25.12M-83.76%10.78M19.94%66.35M-75.16%18.75M
Current changes in cash 195.30%13.01M-608.49%-39.8M180.97%40.31M106.40%3.56M-20.19%-9.58M149.11%4.41M23.28%-5.62M145.82%14.35M-603.82%-55.57M12.56%-7.97M
End cash Position 16.50%27.85M-23.90%14.84M117.50%54.64M33.00%14.33M33.00%14.33M27.55%23.91M-29.63%19.5M-28.30%25.12M-83.76%10.78M-83.76%10.78M
Free cash flow -54.98%-20.6M-42.20%-19.13M-15.88%-15.18M-33.64%-50.87M-14.03%-11.03M-34.87%-13.29M-58.02%-13.45M-30.64%-13.1M-53.97%-38.06M-70.32%-9.67M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data